Merck Careers

Research-based biopharmaceutical company operating as MSD outside the United States and Canada.

merck.com

About the company

Legal name

Merck & Co., Inc.

Known outside US and Canada as

MSD

Headquarters

Rahway, New Jersey, United States

Business areas

Pharmaceuticals, vaccines, and animal health

Employees

About 75,000 (December 31, 2025)

Revenue (FY2025)

US$65.0 billion

R&D expense (FY2025)

US$15.8 billion

CEO

Robert M. Davis

Listed on

NYSE: MRK

Website

merck.com

Merck & Co., Inc. is a research-based biopharmaceutical company headquartered in Rahway, New Jersey. The company is known as MSD outside the United States and Canada and is listed on the New York Stock Exchange under the ticker MRK.

Its businesses span prescription medicines, vaccines, biologic therapies, and animal health products. The company sells products through its pharmaceutical and animal health segments.

Merck reported revenue of US$65.0 billion and research and development expense of US$15.8 billion for 2025. It employed about 75,000 people at December 31, 2025.

Key People

Robert M. Davis

Chairman and Chief Executive Officer

Caroline Litchfield

Executive Vice President and Chief Financial Officer

Dean Y. Li

Executive Vice President and President, Merck Research Laboratories

Joseph Romanelli

President, MSD International Human Health

Interview process at Merck

(Based on 31 interview reviews)

Interview experience

3.7 out of 5

Interview difficulty

Mostly moderate

Interview process length

Reported across five source buckets

Overall experience

PoorExcellent

Prep for your Merck interview with AI

Practice real Merck questions and get instant AI feedback.

Merck Interview Questions & Answers

Q: Tell me about yourself and your resume.

A: Give a concise career summary, connect two relevant achievements to the role, and close with why this opportunity is the logical next step.

Answer by AI

Start with your current specialty and years of relevant experience.
Select two measurable achievements that match the role.
End with the skills you want to apply in this position.

Q: Tell me about a time you experienced conflict, an issue, or a difficult period in your daily work.

A: Use a situation, task, action, and result structure. Explain the disagreement plainly, show how you listened and acted, and state what changed.

Answer by AI

Choose a real conflict where your own actions are clear.
Describe how you found common ground and made a decision.
Quantify the result and mention what you learned.

Q: Why would you be a good fit?

A: Match your experience to the main requirements and support each claim with an example. Focus on team outcomes, judgment, and the work named in the role.

Answer by AI

Identify the three most important requirements in the posting.
Pair each requirement with a concise achievement.
Avoid broad claims that do not have supporting evidence.

Q: Explain your most recent experience.

A: Describe your scope, team, priorities, and one meaningful result from your latest role. Separate your own contribution from the wider team's work.

Answer by AI

Set context with role, team size, and business objective.
Explain one decision or action you personally owned.
Close with a measurable outcome and relevant lesson.

Prep for your Merck interview with AI

Practice real Merck questions and get instant AI feedback.

Merck Salaries in India (Updated 2026)

Therapy Manager

2 to 15 years

₹8.0 lakh to ₹8.8 lakh per year

104 Salaries submitted

Senior Therapy Manager

10 to 20 years

₹10.2 lakh to ₹11.3 lakh per year

76 Salaries submitted

Software Engineering Specialist

4 to 5 years

₹24.7 lakh to ₹28.5 lakh per year

57 Salaries submitted

Data Science Manager

7 to 8 years

₹23.9 lakh to ₹27.7 lakh per year

57 Salaries submitted

Team Manager

4 to 9 years

₹23.2 lakh to ₹27.7 lakh per year

38 Salaries submitted

Associate Data Science Manager

1 to 5 years

₹13.4 lakh to ₹17.3 lakh per year

33 Salaries submitted

Know your worth at Merck

Compare reported pay ranges and find roles that fit your experience.

Open roles

Senior Manager Strategic Forecasting

Pune, Maharashtra, India • Full-Time

Senior Specialist, AEM DAM Developer (AEM Assets)

Hyderabad, Telangana, India • Full-Time

Specialist, Capability Innovation & Prototype (AI Content Delivery & Partnerships)

Hyderabad, Telangana, India • Full-Time

Specialist, Asset Management (Digital Asset Librarian - AEM Assets)

Hyderabad, Telangana, India • Full-Time

Manager Strategic Forecasting

Pune, Maharashtra, India • Full-Time

Associate Director, Commercial AI - Tech Lead

Hyderabad, Telangana, India • Full-Time

Build a standout resume with AI

Turn your experience into a focused resume for Merck roles.

Benefits

Professional development opportunities

Global recognition program

Short- and long-term incentives

Health insurance

Life insurance

Disability insurance

Business travel insurance

Mental health therapy sessions

Fitness and health resources

Vacation and holidays

Year-end shutdown

Latest News & Updates

July 21, 2026

Once-weekly oral HIV regimen maintained virological suppression in study

Merck and Gilead reported study results for an investigational once-weekly oral regimen of islatravir and lenacapavir in adults who switched treatment.

#Research #HIV

View post

July 16, 2026

FDA approves once-daily oral PCSK9 inhibitor LIPFENDRA

Merck announced US FDA approval of LIPFENDRA to reduce LDL cholesterol in adults with hypercholesterolemia.

#FDA #Cardiovascular

View post

July 15, 2026

Merck to present HIV pipeline data at AIDS 2026

The company said it would present research on daily, weekly, and monthly HIV treatment and prevention options at AIDS 2026.

#HIV #ClinicalResearch

View post

July 15, 2026

KEYTRUDA monotherapy improved progression-free survival in study

Merck reported that KEYTRUDA monotherapy met the progression-free survival endpoint in certain patients with advanced or recurrent endometrial cancer.

#Oncology #ClinicalTrial

View post

July 10, 2026

FDA approves KEYTRUDA regimens with PADCEV for bladder cancer

Merck announced FDA approval of KEYTRUDA and KEYTRUDA QLEX with PADCEV for treatment before and after surgery in certain patients with muscle-invasive bladder cancer.

#Oncology #FDA

View post

See all updates